SOLX Titanium Sapphire Laser for Trabeculoplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
GlaucomaGlaucoma, Open Angle
Interventions
DEVICE

SOLX Titanium Sapphire Laser (TiSaLT)

Spot laser treatment, \~50 spots over 180°

DEVICE

Argon Laser Trabeculoplasty (ALT)

Spot laser treatment, \~50 spots over 180°

Trial Locations (10)

10003

Glaucoma Associates of New York, New York

28040

Hospital Clinico San Carlos de Madrid, Madrid

33603

International Eye Care, Tampa

52621

Sheba Medical Center, Tel Litwinsky

64239

Sourasky Medical Center, Tel Aviv

77002

Mann Eye Institute, Houston

78705

Texan Eye Care, Austin

94954

North Bay Eye Associates, Petaluma

L5L 1W8

Credit Valley EyeCare, Mississauga

H1V 1G5

Institut du Glaucome de Montréal, Montreal

All Listed Sponsors
lead

SOLX, Inc.

INDUSTRY

NCT00145535 - SOLX Titanium Sapphire Laser for Trabeculoplasty | Biotech Hunter | Biotech Hunter